Development code · Small Molecule
SSR149415
SSR149415 is a development code for Nelivaptan (BH-200), developed by Sanofi.
- Status
- Phase 2 for Major depressive disorder
- Mechanism
- V1B receptor Antagonist
- Developer
- Sanofi
Programs
- Nelivaptan (BH-200) for Major depressive disorderPhase 2Active
Also known as
- BH-200
- SSR-149415
- SR-149415
- BH200
- Nelivabon
- nelivaptan
- 439687-69-1
- (2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide